Biograph has launched a dedicated Women's Health Program integrating hormone testing, menopause care, and longitudinal risk assessment into its preventive model. The initiative addresses a structural gap in US women's healthcare: a 2024 report documents that American women have life expectancy two years shorter than comparable nations and the highest avoidable mortality rate, despite higher healthcare spending.
Key Points
- 71% of female Black-tier members reversed insulin resistance and reduced cardiovascular risk
- 87% of women with moderate-to-severe menopause symptoms never sought medical care
- Program integrates reproductive history, hormone testing, and multi-system risk assessment
Longevity Analysis
The program reflects a critical recognition: women's health requires integrated assessment across multiple physiological domains rather than isolated annual examinations. Menopause represents a major biological inflection point affecting cardiovascular, metabolic, bone, and cognitive function simultaneously. By connecting reproductive and hormonal history to risk markers across systems, the model shifts from reactive symptom management to prospective risk identification—a necessary step for populations structurally underserved by standard preventive care frameworks. The measurable reversal of insulin resistance in a substantial cohort demonstrates that targeted, data-informed intervention during this transition period can alter trajectory for multiple age-related diseases.
Original published by Longevity.Technology, by Kyle Umipig.